Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Examining the Pathways Between Self-Awareness and Well-Being in Mild to Moderate Alzheimer Disease.

Cines S, Farrell M, Steffener J, Sullo L, Huey E, Karlawish J, Cosentino S.

Am J Geriatr Psychiatry. 2015 Dec;23(12):1297-306. doi: 10.1016/j.jagp.2015.05.005.

2.

Do Subjective Memory Complaints Lead or Follow Objective Cognitive Change? A Five-Year Population Study of Temporal Influence.

Snitz BE, Small BJ, Wang T, Chang CC, Hughes TF, Ganguli M.

J Int Neuropsychol Soc. 2015 Oct;21(9):732-42. doi: 10.1017/S1355617715000922.

3.

Cognitive correlates of metamemory in Alzheimer's disease.

Shaked D, Farrell M, Huey E, Metcalfe J, Cines S, Karlawish J, Sullo E, Cosentino S.

Neuropsychology. 2014 Sep;28(5):695-705. doi: 10.1037/neu0000078.

4.

Metacognition in the behavioral variant of frontotemporal dementia and Alzheimer's disease.

Rosen HJ, Alcantar O, Zakrzewski J, Shimamura AP, Neuhaus J, Miller BL.

Neuropsychology. 2014 May;28(3):436-47. doi: 10.1037/neu0000012.

5.

Neurobiology of delusions, memory, and insight in Alzheimer disease.

Sultzer DL, Leskin LP, Melrose RJ, Harwood DG, Narvaez TA, Ando TK, Mandelkern MA.

Am J Geriatr Psychiatry. 2014 Nov;22(11):1346-55. doi: 10.1016/j.jagp.2013.06.005.

6.
7.

Design, methods and demographic findings of the DEMINVALL survey: a population-based study of Dementia in Valladolid, Northwestern Spain.

Tola-Arribas MA, Garea MJ, Yugueros MI, Ortega-Valín F, Cerón A, Fernández-Malvido B, González-Touya M, San José A, Botrán A, Iglesias V, Díaz-Gómez B; DEMINVALL study group..

BMC Neurol. 2012 Aug 30;12:86. doi: 10.1186/1471-2377-12-86.

9.

Anosognosia for behavioral disturbances in frontotemporal dementia and corticobasal syndrome: A voxel-based morphometry study.

Zamboni G, Grafman J, Krueger F, Knutson KM, Huey ED.

Dement Geriatr Cogn Disord. 2010;29(1):88-96. doi: 10.1159/000255141.

10.

Neuroanatomical correlates of cognitive self-appraisal in neurodegenerative disease.

Rosen HJ, Alcantar O, Rothlind J, Sturm V, Kramer JH, Weiner M, Miller BL.

Neuroimage. 2010 Feb 15;49(4):3358-64. doi: 10.1016/j.neuroimage.2009.11.041.

11.

Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.

Riepe MW, Mittendorf T, Förstl H, Frölich L, Haupt M, Leidl R, Vauth C, von der Schulenburg MG.

BMC Neurol. 2009 Aug 25;9:47. doi: 10.1186/1471-2377-9-47.

12.

Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Cosentino S, Metcalfe J, Butterfield B, Stern Y.

Cortex. 2007 Oct;43(7):1004-19.

13.

Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal.

Ries ML, Jabbar BM, Schmitz TW, Trivedi MA, Gleason CE, Carlsson CM, Rowley HA, Asthana S, Johnson SC.

J Int Neuropsychol Soc. 2007 May;13(3):450-61.

14.

A diagnostic formulation for anosognosia in Alzheimer's disease.

Starkstein SE, Jorge R, Mizrahi R, Robinson RG.

J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):719-25.

15.

Metacognitive deficits in frontotemporal dementia.

Eslinger PJ, Dennis K, Moore P, Antani S, Hauck R, Grossman M.

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1630-5.

16.

Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease.

Marshall GA, Kaufer DI, Lopez OL, Rao GR, Hamilton RL, DeKosky ST.

J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1396-400.

17.

Quality of Life measures for dementia.

Ready RE, Ott BR.

Health Qual Life Outcomes. 2003 Apr 23;1:11. Review.

18.

Two domains of anosognosia in Alzheimer's disease.

Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R.

J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):485-90.

Items per page

Supplemental Content

Support Center